Literature DB >> 33791404

Checkpoint Inhibitor-Induced Gastroduodenitis: An Unusual Manifestation.

Rui Mendo1, Pedro Figueiredo1,2, Luís Mascarenhas3.   

Abstract

Keywords:  Gastroduodenitis; Immune-checkpoint inhibitors; Pembrolizumab

Year:  2020        PMID： 33791404      PMCID： PMC7991272          DOI： 10.1159/000509196

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN： 2387-1954


× No keyword cloud information.
  4 in total

Review 1.  Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor.

Authors:  Marta Rocha; João Correia de Sousa; Marta Salgado; António Araújo; Isabel Pedroto
Journal:  GE Port J Gastroenterol       Date:  2018-12-17

2.  Morphological spectrum of immune check-point inhibitor therapy-associated gastritis.

Authors:  Melanie Johncilla; Shilpa Grover; Xuchen Zhang; Dhanpat Jain; Amitabh Srivastava
Journal:  Histopathology       Date:  2020-02-18       Impact factor: 5.087

Review 3.  Immune checkpoint inhibitor-related luminal GI adverse events.

Authors:  Paul T Kröner; Kabir Mody; Francis A Farraye
Journal:  Gastrointest Endosc       Date:  2019-09-14       Impact factor: 9.427

Review 4.  Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management.

Authors:  Mark A Samaan; Polychronis Pavlidis; Sophie Papa; Nick Powell; Peter M Irving
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-03-07       Impact factor: 46.802
  4 in total
  2 in total

1.  Immune Checkpoint Inhibitor-Induced Gastroduodenitis: Recurrence after Rechallenge with Pembrolizumab.

Authors:  Catarina O'Neill; Rui Mendo; Pedro C Figueiredo
Journal:  GE Port J Gastroenterol       Date:  2021-04-20

Review 2.  Checkpoint Inhibitors and Induction of Celiac Disease-like Condition.

Authors:  Aaron Lerner; Carina Benzvi
Journal:  Biomedicines       Date:  2022-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.